Literature DB >> 2157243

Accelerated fractionation in advanced head and neck cancer: results and analysis of late sequelae.

P Olmi1, E Cellai, A Chiavacci, C Fallai.   

Abstract

From 1975 to 1985, 161 patients affected by head and neck cancer (58 oropharynx, 67 oral cavity, 36 paranasal sinuses) were treated with radiotherapy using an accelerated fractionation (AF) schedule at the University and Hospital Radiotherapy Departments of Florence. Most cases, classified with U.I.C.C. and A.J.C. TNM (1978) were advanced (137/161 = 85%). Five-year actuarial local control and survival was 38% for the oropharynx, 18% and 20% for the oral cavity, and 38% and 31% for the paranasal sinuses. Results were analysed according to T and N stage as well. Severe late sequelae were evaluated in 53 patients without local disease and with a minimum follow-up of one year: 8 patients developed osteonecrosis; there were 3 cases of trismus, 2 cases of laryngeal oedema, one case of blindness and one case of ophthalmitis.

Entities:  

Mesh:

Year:  1990        PMID: 2157243     DOI: 10.1016/0167-8140(90)90204-a

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  4 in total

1.  A prospective investigation of swallowing, nutrition, and patient-rated functional impact following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer.

Authors:  Bena Cartmill; Petrea Cornwell; Elizabeth Ward; Wendy Davidson; Sandro Porceddu
Journal:  Dysphagia       Date:  2011-02-23       Impact factor: 3.438

2.  Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee.

Authors:  M I Saunders; S Dische; A Barrett; M K Parmar; A Harvey; D Gibson
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

3.  MR imaging of nonmalignant polyps and masses of the nasopharynx and sphenoid sinus after radiotherapy for nasopharyngeal carcinoma.

Authors:  A D King; A T Ahuja; S-F Leung; J Abrigo; J K T Wong; W S Poon; K S Woo; H S Chan; G M K Tse
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-08       Impact factor: 3.825

4.  How does radiotherapy impact swallowing function in nasopharynx and oropharynx cancer? Short-term results of a prospective study.

Authors:  S Ursino; V Seccia; P Cocuzza; P Ferrazza; T Briganti; F Matteucci; L Fatigante; P Giusti; M Grosso; L Locantore; R Morganti; A Nacci; S Sellari Franceschini; F Paiar; D Caramella; B Fattori
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-03-31       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.